4.4 Editorial Material

International Diabetes Federation position statement on bariatric surgery for type 2 diabetes: implications for patients, physicians, and surgeons

期刊

SURGERY FOR OBESITY AND RELATED DISEASES
卷 7, 期 4, 页码 448-451

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.soard.2011.05.015

关键词

-

类别

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Metabolic effects of duodenojejunal bypass surgery in a rat model of type 1 diabetes

Roman Vangoitsenhoven, Rickesha Wilson, Gautam Sharma, Suriya Punchai, Ricard Corcelles, Dvir Froylich, Anny Mulya, Philip R. Schauer, Stacy A. Brethauer, John P. Kirwan, Naseer Sangwan, J. Mark Brown, Ali Aminian

Summary: In BBDP/Wor rats, duodenojejunal bypass (DJB) surgery does not prevent the development of autoimmune type 1 diabetes, but it reduces the need for exogenous insulin and provides other metabolic benefits such as weight loss, increased GLP-1 secretion, reduced hepatic stress, and alterations in gut microbiome.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2021)

Article Surgery

Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients

Linden A. Karas, Zubaidah Nor Hanipah, Derrick Cetin, Philip R. Schauer, Stacy A. Brethauer, Christopher R. Daigle, Ali Aminian

Summary: Thromboprophylaxis after bariatric surgery with enoxaparin may not reach optimal levels in obese patients. AFXa testing can reveal that both underdosing and overdosing of prophylactic enoxaparin are common in this population. More accurate dosing strategies may be needed to prevent thromboembolic complications.

SURGERY FOR OBESITY AND RELATED DISEASES (2021)

Article Endocrinology & Metabolism

Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats

J. David Mosinski, Ali Aminian, Christopher L. Axelrod, Esam Batayyah, Hector Romero-Talamas, Christopher Daigle, Anny Mulya, Amanda Scelsi, Philip R. Schauer, Stacy A. Brethauer, John P. Kirwan

Summary: This study shows that RYGB surgery can improve weight, glucose tolerance, and insulin secretion in ZDF rats. It suggests that RYGB surgery can restore balance in glucose and insulin levels, contributing to the remission of type 2 diabetes.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)

Article Endocrinology & Metabolism

Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery

Roman Vangoitsenhoven, Rickesha L. Wilson, Deepa V. Cherla, Chao Tu, Sangeeta R. Kashyap, David E. Cummings, Philip R. Schauer, Ali Aminian

Summary: This study suggests that presence of liver steatosis in patients with T2DM undergoing bariatric surgery is associated with better long-term glycemic outcomes, indicating distinct variants of T2DM with different metabolic responses to surgical weight loss.

DIABETES CARE (2021)

Review Surgery

SARS-CoV-2 and Obesity: CoVesity-a Pandemic Within a Pandemic

Kimberley Zakka, Swathikan Chidambaram, Sami Mansour, Kamal Mahawar, Paulina Salminen, Ramos Almino, Philip Schauer, James Kinross, Sanjay Purkayastha

Summary: Individuals who are overweight or suffering from obesity are more likely to be in a chronic state of inflammation, leading to greater susceptibility to severe respiratory failure. Previous studies have linked obesity with worse health outcomes, particularly in the context of pandemics. The safe resumption of obesity management services is necessary to mitigate the health outcomes of this vulnerable population.

OBESITY SURGERY (2021)

Editorial Material Cardiac & Cardiovascular Systems

After 70 Years, Metabolic Surgery Has Earned a Cardiovascular Outcome Trial

Philip R. Schauer, Steven E. Nissen

CIRCULATION (2021)

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on Evaluation and Management of Early Complications After Bariatric/Metabolic Surgery: Expert Review

Vivek Kumbhari, David E. Cummings, Anthony N. Kalloo, Philip R. Schauer

Summary: This article highlights the importance of endoscopic techniques in managing early complications after bariatric/metabolic surgery and emphasizes the necessity of multidisciplinary collaboration. It discusses the expertise required by clinicians and the lack of standardized evaluation and treatment algorithms in this field.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Letter Endocrinology & Metabolism

Bias in electronic health record-based studies: Seeing the forest for the trees

David Arterburn, Ali Aminian, Steve Nissen, Phil Schauer, Sebastien Haneuse

DIABETES OBESITY & METABOLISM (2021)

Article Endocrinology & Metabolism

Foregut Exclusion Enhances Incretin and Insulin Secretion After Roux-en-Y Gastric Bypass in Adults With Type 2 Diabetes

John P. Kirwan, Christopher L. Axelrod, Emily L. Kullman, Steven K. Malin, Wagner S. Dantas, Kathryn Pergola, Juan Pablo del Rincon, Stacy A. Brethauer, Sangeeta R. Kashyap, Philip R. Schauer

Summary: The study showed that patients with type 2 diabetes undergoing Roux-en-Y gastric bypass (RYGB) surgery experienced significant reductions in body weight, fat mass, fasting glucose and insulin levels, and circulating lipids 2 weeks post-operation. Oral feeding enhanced insulin and incretin secretion after RYGB, while G-tube feeding completely abolished this enhancement, suggesting that foregut exclusion plays a role in improving glucose metabolism after RYGB, but may not be the sole explanation.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Surgery

Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes Insights From the STAMPEDE Randomized Trial

Ali Aminian, Sangeeta R. Kashyap, Kathy E. Wolski, Stacy A. Brethauer, John P. Kirwan, Steven E. Nissen, Deepak L. Bhatt, Philip R. Schauer

Summary: This study found that metabolic surgery in patients with T2DM is associated with long-term favorable changes in certain patient-reported outcomes compared with intensive medical therapy, particularly in physical health and diabetes-related domains. The effects on psychosocial well-being were similar among the study groups.

ANNALS OF SURGERY (2021)

Article Endocrinology & Metabolism

Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care

Ali Aminian, Rickesha Wilson, Alexander Zajichek, Chao Tu, Kathy E. Wolski, Philip R. Schauer, Michael W. Kattan, Steven E. Nissen, Stacy A. Brethauer

Summary: The study findings suggest that in patients with obesity and type 2 diabetes mellitus, Roux-en-Y gastric bypass (RYGB) surgery may be associated with greater weight loss, better diabetes control, and lower risk of major adverse cardiovascular events (MACE) and nephropathy compared with sleeve gastrectomy (SG) surgery.

DIABETES CARE (2021)

Article Peripheral Vascular Disease

Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association

Michael E. Hall, Jordana B. Cohen, Jamy D. Ard, Brent M. Egan, John E. Hall, Carl J. Lavie, Jun Ma, Chiadi E. Ndumele, Philip R. Schauer, Daichi Shimbo

Summary: Obesity is a major risk factor for primary hypertension, and lifestyle modification is usually recommended for obese patients, but long-term success is limited.

HYPERTENSION (2021)

Article Endocrinology & Metabolism

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes

Matthew C. Riddle, William T. Cefalu, Philip H. Evans, Hertzel C. Gerstein, Michael A. Nauck, William K. Oh, Amy E. Rothberg, Carel W. le Roux, Francesco Rubino, Philip Schauer, Roy Taylor, Douglas Twenefour

Summary: Improvement of glucose levels in people with diabetes can occur spontaneously or after medical interventions. Newer forms of treatment may lead to more sustained improvement. However, the terminology and objective measures for defining this process are not established, and the long-term risks and benefits are not well understood. An international expert group proposed the term "remission" and HbA1c < 6.5% as the usual diagnostic criterion. They also suggested active observation and further research on predictors and outcomes of remission.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Medicine, General & Internal

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

Ali Aminian, Abbas Al-Kurd, Rickesha Wilson, James Bena, Hana Fayazzadeh, Tavankit Singh, Vance L. Albaugh, Faiz U. Shariff, Noe A. Rodriguez, Jian Jin, Stacy A. Brethauer, Srinivasan Dasarathy, Naim Alkhouri, Philip R. Schauer, Arthur J. McCullough, Steven E. Nissen

Summary: Among patients with NASH and obesity, bariatric surgery was associated with a significantly lower risk of incident major adverse liver outcomes and MACE compared with nonsurgical management.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Surgery

Is COVID-19 the Newest Comorbidity of Obesity Mitigated by Bariatric Surgery?

Paulina Salminen, Gerhard Prager, Phil R. Schauer

JAMA SURGERY (2022)

暂无数据